New study shows patients experience asthma variability, despite strict adherence to guidelines

November 15, 2004

BOSTON, Nov. 15 - A study presented today at the 62nd Annual Meeting of the American College of Allergy, Asthma and Immunology shows that many patients with asthma continue to experience variability of disease control, despite strict adherence to treatment guidelines published by the National Heart, Lung and Blood Institute.(1) Variability in asthma control leads to continued disease symptoms and increased resource utilization, even when the disease is closely managed.

Although patients enrolled in the study experienced reductions in hospitalizations, emergency visits and clinic visits, researchers found important differences between those classified as having "high variability" and those with "low variability" of disease symptoms. Specifically:

  • Patients in the high variability group experienced greater overall direct and indirect costs, measured by number of emergency department visits, hospitalizations and days lost from work, school or daily activities of living. These patients also experienced more "sick visits," measured by unscheduled routine follow-up visits to primary care physicians, asthma clinics or urgent care facilities than those in the low variability group.(1)

  • Hospitalization, emergency room visits and clinic visit costs for treating asthma of high variability patients were estimated at $163 per patient per month, twice the cost for treating low variability patients ($81 per patient per month).

  • 74 percent of patients in the high variability group used rescue bronchodilators daily for more than half of the weeks of the observation period, compared to less than half (47 percent) of the patients in the low variability group.(1)

  • Asthma interrupted daily activity more often for patients in the high variability group. On average, high variability patients reported that asthma caused them to miss work, school, exercise or social activities 1.84 days per patient per month. Low variability patients reported missing activities 1.25 days per patient per month.(1)

    "Asthma is a highly variable disease, and patients may continue to suffer from symptoms as a result, despite adherence to practice guidelines," said Ileen Gilbert, MD, Professor of Medicine, Medical College of Wisconsin, lead investigator of the study. "We still need to know more about the underlying pathophysiology of the disease as well as more about environmental factors that trigger events and how to modify them in order to fully treat and reduce costs of this complicated disorder."

    Study Design and Methodology

    The analysis of the study, supported by AstraZeneca, assessed asthma variability in 125 inner-city patients (72 percent female; 68 percent minority [African- and Hispanic-American]; 80 percent treated by primary care physicians) in a period beginning six months prior to enrollment into an NHLBI guidelines-directed clinical and education intervention to minimize barriers to adherence, and ending six months following enrollment. Patients were stratified into two groups: those with high variability in asthma, and those with low variability. For purposes of the study, variability was defined as the number of fluctuations in NAEPP symptom class in the six-month post- intervention period. The 62 patients in the high variability group changed their NAEPP symptom class about once every other month, or more frequently. All other patients were classified as having symptoms in the low variability group.

    About Asthma Asthma is one of the most serious chronic medical conditions in the United States. In 2002, it was estimated that 20 million Americans have asthma. Of these, nearly 12 million Americans had an asthma attack or episode in the past year. Additionally, it is estimated that more than 30 million Americans, or about 10 percent of the U.S. population, have been diagnosed with asthma at some point in their lives.(2)

    Asthma is a reversible obstructive lung disease, caused by increased reaction of the airways to various stimuli, such as cigarette smoke, airborne molds, pollens, dust, animal dander, exercise, cold air, many household and industrial products, air pollutants, scents or simple stress. It is a chronic inflammatory condition that usually leads to breathing problems known as "episodes" - a series of events that result in narrowed airways - which is responsible for the difficulty in breathing with the familiar wheeze.(3)

    Although each person reacts differently to the factors that may trigger asthma, it can be a life-threatening disease if it is not properly managed. According to the American Lung Association, more than 4,200 Americans died from asthma in 2001.(2)
    About AstraZeneca

    AstraZeneca (NYSE: AZN) is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. In the United States, AstraZeneca is an $8.7 billion healthcare business with more than 11,000 employees. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.

    For more information about AstraZeneca, please visit:

    (1) Gilbert IA, Perry SM, Olivares A, et al. Resource utilization associated with asthma variability in patients with mild, moderate, or severe persistent asthma adhering to national asthma education prevention program therapy guidelines. Abstract presented at 62nd Annual Meeting of the American College of Allergy, Asthma and Immunology, November 12, 2004

    (2) Trends in Asthma Morbidity and Mortality, American Lung Association, April 2004

    (3) Asthma in Adults Fact Sheet, American Lung Association, July 2003


    Related Asthma Articles from Brightsurf:

    Breastfeeding and risks of allergies and asthma
    In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

    Researchers make asthma breakthrough
    Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

    Physics vs. asthma
    A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

    New knowledge on the development of asthma
    Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

    Eating fish may help prevent asthma
    A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

    Academic performance of urban children with asthma worse than peers without asthma
    A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

    Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
    The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

    Asthma management tools improve asthma control and reduce hospital visits
    A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

    Asthma linked to infertility but not among women taking regular asthma preventers
    Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

    What are the best ways to diagnose and manage asthma?
    A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

    Read More: Asthma News and Asthma Current Events
  • is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to